MARKSANS PHARMA Q2 FY25 Results
MARKSANS PHARMA has released its financial results for the Q2 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 641.92 Cr
- Quarter-on-Quarter (QoQ) Change: 8.69% (Previous Quarter: Rs. 590.62 Cr )
- Year-on-Year (YoY) Change: 20.84% (Same Quarter Last Year: Rs. 531.24 Cr )
Profitability Metrics
- Net Profit: Rs. 97.76 Cr
- QoQ Profit Change: 9.76% (Previous Quarter: Rs. 89.07 Cr )
- YoY Profit Change: 16.59% (Same Quarter Last Year: Rs. 83.85 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 2.13
- QoQ EPS Change: 8.67% (Previous Quarter: Rs. 1.96)
- YoY EPS Change: 15.76% (Same Quarter Last Year: Rs. 1.84)
Performance Summary
Strong
MARKSANS PHARMA grew steadily in both sales and profits. This shows a stable and healthy business.
This analysis provides a snapshot of MARKSANS PHARMA's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.